Thomas C. Hohman

1.9k total citations
40 papers, 1.6k citations indexed

About

Thomas C. Hohman is a scholar working on Cell Biology, Molecular Biology and Physiology. According to data from OpenAlex, Thomas C. Hohman has authored 40 papers receiving a total of 1.6k indexed citations (citations by other indexed papers that have themselves been cited), including 19 papers in Cell Biology, 16 papers in Molecular Biology and 11 papers in Physiology. Recurrent topics in Thomas C. Hohman's work include Aldose Reductase and Taurine (18 papers), Prenatal Substance Exposure Effects (9 papers) and Retinal Diseases and Treatments (9 papers). Thomas C. Hohman is often cited by papers focused on Aldose Reductase and Taurine (18 papers), Prenatal Substance Exposure Effects (9 papers) and Retinal Diseases and Treatments (9 papers). Thomas C. Hohman collaborates with scholars based in United States, Canada and United Kingdom. Thomas C. Hohman's co-authors include Deborah Carper, Chihiro Nishimura, W. Gerald Robison, Steffen Schmitz-Valckenberg, Monika Fleckenstein, Frank G. Holz, Jane Millen, Norman E. Cameron, Masayuki Kaneko and Jay Wrobel and has published in prestigious journals such as Molecular and Cellular Biology, Diabetes Care and Biochemical and Biophysical Research Communications.

In The Last Decade

Thomas C. Hohman

38 papers receiving 1.6k citations

Peers

Thomas C. Hohman
Per J. Wistrand Sweden
Margaret H. Garner United States
Miki Hiraoka Japan
Penny Roon United States
M. Christine McGahan United States
Rebecca J. Kapphahn United States
Junko Matsuda Japan
Thomas W. Mittag United States
Natalia Abuladze United States
Xiangjun Yang China
Per J. Wistrand Sweden
Thomas C. Hohman
Citations per year, relative to Thomas C. Hohman Thomas C. Hohman (= 1×) peers Per J. Wistrand

Countries citing papers authored by Thomas C. Hohman

Since Specialization
Citations

This map shows the geographic impact of Thomas C. Hohman's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Thomas C. Hohman with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Thomas C. Hohman more than expected).

Fields of papers citing papers by Thomas C. Hohman

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Thomas C. Hohman. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Thomas C. Hohman. The network helps show where Thomas C. Hohman may publish in the future.

Co-authorship network of co-authors of Thomas C. Hohman

This figure shows the co-authorship network connecting the top 25 collaborators of Thomas C. Hohman. A scholar is included among the top collaborators of Thomas C. Hohman based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Thomas C. Hohman. Thomas C. Hohman is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Patel, Chintan, Robin J Goody, Wenzheng Hu, et al.. (2020). Primate model of chronic retinal neovascularization and vascular leakage. Experimental Eye Research. 195. 108031–108031. 8 indexed citations
2.
Callanan, David, Derek Kunimoto, Raj K. Maturi, et al.. (2018). Double-Masked, Randomized, Phase 2 Evaluation of Abicipar Pegol (an Anti-VEGF DARPin Therapeutic) in Neovascular Age-Related Macular Degeneration. Journal of Ocular Pharmacology and Therapeutics. 34(10). 700–709. 55 indexed citations
3.
Hohman, Thomas C.. (2016). Hereditary Retinal Dystrophy. Handbook of experimental pharmacology. 242. 337–367. 32 indexed citations
4.
Schmitz-Valckenberg, Steffen, Monika Fleckenstein, Arno P. Göbel, Thomas C. Hohman, & Frank G. Holz. (2010). Optical Coherence Tomography and Autofluorescence Findings in Areas with Geographic Atrophy Due to Age-Related Macular Degeneration. Investigative Ophthalmology & Visual Science. 52(1). 1–1. 83 indexed citations
5.
Akamine, Eliana Hiromi, Thomas C. Hohman, Dorothy Nigro, et al.. (2003). Minalrestat, an Aldose Reductase Inhibitor, Corrects the Impaired Microvascular Reactivity in Diabetes. Journal of Pharmacology and Experimental Therapeutics. 304(3). 1236–1242. 24 indexed citations
6.
Jacot, J. L., et al.. (2000). Retinal Capillary Dilation: Early Diabetic-Like Retinopathy in the Galactose-Fed Rat Model. Journal of Ocular Pharmacology and Therapeutics. 16(2). 167–172. 6 indexed citations
7.
Hohman, Thomas C., M. A. Cotter, & Norman E. Cameron. (2000). ATP-sensitive K+ channel effects on nerve function, Na+, K+ ATPase, and glutathione in diabetic rats. European Journal of Pharmacology. 397(2-3). 335–341. 27 indexed citations
8.
Filep, János G., et al.. (1999). Molecular mechanisms of glucose action on angiotensinogen gene expression in rat proximal tubular cells. Kidney International. 55(2). 454–464. 104 indexed citations
9.
Hohman, Thomas C., et al.. (1998). Probing the inhibitor‐binding site of aldose reductase with site‐directed mutagenesis. European Journal of Biochemistry. 256(2). 310–316. 21 indexed citations
10.
Cameron, Norman E., M. A. Cotter, K. C. Dines, & Thomas C. Hohman. (1996). Reversal of defective peripheral nerve conduction velocity, nutritive endoneurial blood flow, and oxygenation by a novel aldose reductase inhibitor, WAY-121,509, in streptozotocin-induced diabetic rats. Journal of Diabetes and its Complications. 10(1). 43–53. 24 indexed citations
11.
Malamas, Michael S. & Thomas C. Hohman. (1994). N-Substituted Spirosuccinimide, Spiropyridazine, Spiroazetidine, and Acetic Acid Aldose Reductase Inhibitors Derived from Isoquinoline-1,3-diones. 2. Journal of Medicinal Chemistry. 37(13). 2059–2070. 22 indexed citations
12.
Kamijo, Mikiko, Michael Basso, Paul Cherian, Thomas C. Hohman, & Anders A. F. Sima. (1994). Galactosemia produces ARI-preventable nodal changes similar to those of diabetic neuropathy. Diabetes Research and Clinical Practice. 25(2). 117–129. 16 indexed citations
13.
Hohman, Thomas C. & Blair Bowers. (1993). Hydrolase Compartmentalization Limits Rate of Digestion in Acanthamoeba. Journal of Eukaryotic Microbiology. 40(5). 589–593. 1 indexed citations
14.
Sima, Anders A. F., Douglas A. Greene, Morton B. Brown, et al.. (1993). Effect of hyperglycemia and the aldose reductase inhibitor tolrestat on sural nerve biochemistry and morphometry in advanced diabetic peripheral polyneuropathy. Journal of Diabetes and its Complications. 7(3). 157–169. 57 indexed citations
15.
Carper, Deborah, Masayuki Kaneko, Heather Stark, & Thomas C. Hohman. (1990). Increase in aldose reductase mRNA in dog lens epithelial cells under hypertonic conditions. Experimental Eye Research. 50(6). 743–749. 33 indexed citations
16.
Hohman, Thomas C., Chihiro Nishimura, & W. Gerald Robison. (1989). Aldose reductase and polyol in cultured pericytes of human retinal capillaries. Experimental Eye Research. 48(1). 55–60. 67 indexed citations
17.
Nagata, Masao, Thomas C. Hohman, Chihiro Nishimura, et al.. (1989). Polyol and vacuole formation in cultured canine lens epithelial cells. Experimental Eye Research. 48(5). 667–677. 24 indexed citations
18.
Nishimura, Chihiro, et al.. (1988). Characterization of mRNA and genes for aldose reductase in rat. Biochemical and Biophysical Research Communications. 153(3). 1051–1059. 55 indexed citations
19.
Hohman, Thomas C., et al.. (1988). Purification of Plasma Membrane from Acanthamoeba castellanii1. The Journal of Protozoology. 35(3). 408–413. 15 indexed citations
20.
Russell, Paul, Susan O. Meakin, Thomas C. Hohman, Lap‐Chee Tsui, & Martin L. Breitman. (1987). Relationship Between Proteins Encoded by Three Human γ-Crystallin Genes and Distinct Polypeptides in the Eye Lens. Molecular and Cellular Biology. 7(9). 3320–3323. 3 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Per J. Wistrand Breakdown of academic impact, for papers by Margaret H. Garner Breakdown of academic impact, for papers by Miki Hiraoka Breakdown of academic impact, for papers by Penny Roon Breakdown of academic impact, for papers by M. Christine McGahan Breakdown of academic impact, for papers by Rebecca J. Kapphahn Breakdown of academic impact, for papers by Junko Matsuda Breakdown of academic impact, for papers by Thomas W. Mittag Breakdown of academic impact, for papers by Natalia Abuladze Breakdown of academic impact, for papers by Xiangjun Yang
Rankless by CCL
2026